Investigation path
FIND
Novo Nordisk A/S
NVO
RESOLVE
Ondo Assets · Backed Assets · NA (Derivatives)
3 issuers
TRACE
4 tokenized representations
NVOon · NVOX · NVO
UnderScope Lens
Representation check
A compact comparison of Novo Nordisk A/S across the reported market reference, tokenized aggregate, and issuer wrappers.
Market reference
—
No priced CMC venue reference
Tokenized aggregate
$39.31
Aggregate wrapper price
Wrapper dispersion
+2.84%
3 priced wrappers · wide range
Novo Nordisk A/S has 3 priced issuer wrappers spanning +2.84% from low to high. No priced CMC market reference was available for this check.
Underlier
Novo Nordisk A/S[NVO]
Stock · New York Stock Exchange
Tokenized price
$39.31
Rank #94
- Primary exchange
- New York Stock Exchange
- Founded
- 1923-12-21
- Employees
- 78,387
- CIK
- 0000353278
Tokenized market cap
$2.54M
24h tokenized volume
$1.57M
Tokenized exposure
4wrappers
Source
Average across issuer wrappers, not a cash last
Real-world asset
About the underlier
The instrument being tokenized — not the on-chain wrapper.
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10%…
- Rank
- 94
- Asset type
- Stock
- Primary exchange
- New York Stock Exchange
- Founded
- 1923-12-21
- Employees
- 78,387
- SEC CIK
- 0000353278